Seastar Medical Holding Corp (ICU) - Form 8-K Summary
Business Context and Reporting Period
Seastar Medical Holding Corporation, an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on April 17, 2024. The filing serves to announce the Company's financial results for the twelve months ended December 31, 2023, and provides an operational update. The Company's common stock and warrants trade on the NASDAQ under the symbols ICU and ICUCW, respectively.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the detailed financial results are contained within a press release attached as Exhibit 99.1, which is furnished but not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Material Changes
The filing text does not provide specific data points to compare against prior periods. It references an update on operations and financial results for the year ended December 31, 2023, but the magnitude of any changes is not detailed in the 8-K body text itself.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, specific risks, contingencies, and unusual items are referenced as being included in the attached Press Release (Exhibit 99.1). The 8-K text itself does not elaborate on these qualitative factors or provide specific outlook figures.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 17, 2024) for actual revenue, net income, and cash flow figures for the year ended December 31, 2023.
- Verify the specific operational updates and strategic initiatives mentioned in the press release.
- Check for any forward-looking statements or guidance regarding future performance included in the press release.
- Confirm the status of the Company's emerging growth company election and any related accounting standard transitions.